✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals

Dr. Reddy's Laboratories Ltd.

DRREDDY

Market Cap
₹1,12,681 Cr.
P/E
26.85

Dr. Reddy's Laboratories Ltd.

  • Dr. Reddy's Labs.
  • Zydus Lifesciences
  • Cipla
  • TJI Pharma

FAQs on Dr. Reddy's Laboratories Ltd. Shareprice

Dr. Reddy's Labs. has given lower returns compared to its competitors.
Dr. Reddy's Labs. has grown at ~14.98% over the last 3yrs while peers have grown at a median rate of 24.5%

Yes, Dr. Reddy's Labs. is expensive.
Latest PE of Dr. Reddy's Labs. is 26.85, while 3 year average PE is 21.5.
Also latest EV/EBITDA of Dr. Reddy's Labs. is 17.92 while 3yr average is 14.19.

View FAQ's On Business

Growth Table

  • Dr. Reddy's Laboratories Ltd.
  • Zydus Lifesciences
  • Cipla

Balance Sheet

  • Dr. Reddy's Laboratories Ltd.
  • Zydus Lifesciences
  • Cipla

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Dr. Reddy's Laboratories Ltd.
  • Zydus Lifesciences
  • Cipla

Cash Flow

  • Dr. Reddy's Laboratories Ltd.
  • Zydus Lifesciences
  • Cipla

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Dr. Reddy's Laboratories Ltd.
  • Zydus Lifesciences
  • Cipla

Quarterly Results

  • Dr. Reddy's Laboratories Ltd.
  • Zydus Lifesciences
  • Cipla

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Dr. Reddy's Laboratories Ltd. Financials

Balance sheet of Dr. Reddy's Labs. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Dr. Reddy's Labs. is increasing.
Latest net debt of Dr. Reddy's Labs. is ₹2,945 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹243.7 Crs.

The profit is oscillating.
The profit of Dr. Reddy's Labs. is ₹4,144 Crs for TTM, ₹5,655 Crs for Mar 2025 and ₹5,578 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dr. Reddy's Labs. latest dividend payout ratio is 11.8% and 3yr average dividend payout ratio is 12.85%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech